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represent novel therapeutic tools for the protection and treatment of conditions where attenuated 
dilator responses are observed. 
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ABSTRACT 
Ceria nanoparticles (CeNPs) have attracted considerable interest in the treatment of a number 
of conditions associated with increased production of reactive oxygen species (ROS), due to 
their unique antioxidant properties. We have previously demonstrated the attenuation in 
vasodilation after uptake of silica nanoparticles (SiNPs). Hence, we investigated whether ceria 
coating of SiNPs would improve the magnitude of vasodilation. Ceria coated SiNPs 
(CeSiNPs) were fabricated and fully characterised and their direct  influence on vasodilator 
responses of aortic vessels examined,  ex vivo. We demonstrate that while SiNPs significantly 
attenuate endothelial-dependent (acetylcholine-ACh) vasodilation, their surface modification 
with CeNPs leads to the significant improvement in dilator responses (n=5, p<0.001, at most 
ACh concentrations). These findings have implications in the fabrication of biocompatible 
nanoparticles for medical intervention. Furthermore, CeSiNPs may represent novel 
therapeutic tools for the protection and treatment of conditions where attenuated dilator 
responses are observed. 
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1. INTRODUCTION  
Ceria (Cerium oxide; CeO2) nanoparticles have attracted considerable interest in the 
treatment of conditions associated with increased production of reactive oxygen species 
(ROS), due to their unique antioxidant properties.
1,2
 Ceria nanoparticles (CeNPs) have been 
shown to protect against ischaemic stroke
3
, prevent vision loss due to light induced 
degeneration of photoreceptor cells
4
 and protect normal cells against radiation damage
2
. The 
redox property of CeNPs is due to the large number of surface oxygen vacancies giving it a 
radical scavenging property which has been described to be more efficient than the biological 
antioxidant, superoxide dismutase (SOD).
5
 Silica nanoparticles have potential biomedical 
applications,
6
 but may themselves generate ROS upon cellular uptake.
7-9
 Indeed, we have 
demonstrated that exposure of aortic vessels to silica nanoparticles (SiNPs) attenuated 
vasodilation,
10
 which improved after co-incubation in SOD, suggesting a role for ROS in 
quenching nitric oxide. 
11
  In the present study, we fabricated and characterised ceria coated 
SiNPs (CeSiNPs) and compared their influence on vasodilator responses of aortic vessels with 
SiNPs ex vivo. We suggest that ceria coating of SiNPs will restore vasodilator responses, 
hence increase their biocompatibility for use in therapeutic intervention.  
 
2. EXPERIMENTAL 
2.1. Materials and solutions 
All reagents and agonists were purchased from Sigma-Aldrich (UK). Millipore water 
was used for all experiments.  Physiological Salt Solution (PSS, 60 mM) was prepared as 
previously described.
10
     
 
2.2. Synthesis and Characterisation of nanoparticles 
SiNPs were synthesised via a sol-gel precipitation method as previously described,
11
 
The ceria precursor and ceria nanoparticulate shell was grown on the  SiNPs surface as 
 4 
previously described by Oh et al. (2010).
12
  NPs were prepared for transmission electron 
microscopy (TEM) as previously described.
11
 
 
2.3. Vascular functional studies 
The thoracic aortic arteries of male Wistar rats (150-250 g) were utilised for the in 
vitro studies (n=11 animals; one vessel from each animal). The rats were humanly killed by 
stunning followed by cervical dislocation following institutional approval and in accordance 
with guidelines issued by the European Commission Directive 86/609/EEC. Approximately 
3-4 mm aortic rings were mounted in an organ-bath system (gassed PSS in 95 % O2: 5 % 
CO2; 35 
oC), as previously described and tension recorded using Labchart 6 (Powerlab, AD 
Instruments, UK).
10
 Vessels were pre-constricted with high K⁺ (60 mM, KCl). Responses to 
endothelium-dependent dilator agonist were examined by adding cumulative doses of 
acetylcholine (ACh; 0.01-100 µM), before and after incubation with NPs for 30 min. The 
final concentration of SiNPs, and CeSiNPs placed in the organ-bath experiments were 
1.96 10
12
 NPs mL
-1
. Vessels were fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate 
buffer at pH 7.3. and processes for TEM, as previously described.
10
 
 
2.4. Statistical analysis 
Data are expressed as mean ± standard error of mean (SEM) with ‘n’ representing the 
number of vessels. Dilator responses are expressed as percent relaxation. Concentration 
response curves were assessed using statistical package for the social sciences (SPSS; version 
19). The difference between groups at a given concentration was tested by one way analysis 
of variance (ANOVA) with Bonferroni corrections. Statistical significance is taken as P<0.05.  
 
 
3. RESULTS 
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3.1. Characterisation of nanoparticles 
The SiNPs were monodispersed with an average diameter of 47±8 nm as demonstrated 
by TEM (Fig. 1A). The addition of ceria shell around the SiNPs increased the diameter to 
50±4 nm with the individual CeNPs size of 3.8±1.2 nm (Fig. 1B, C). The energy dispersive 
spectroscopy (EDS) of SiNPs confirms the presence of silica (Fig. 1D). The CeSiNPs contain 
both the silica and ceria (Fig. 1E).  
 
3.2. Influence of nanoparticles on endothelium-dependent vasodilator responses 
All vessels constricted to high potassium physiological salt solution (n=11). 
Incubation in SiNPs (3.03±0.22 g tension and 2.58±0.24 g tension, before and after incubation 
respectively), or CeSiNPs (3.03±0.27 g tension and 2.96±0.32 g tension, before and after 
incubation respectively) had no influence on the magnitude of the constrictor response. All 
pre-constricted vessels dilated to ACh in a dose dependent manner. Incubation in amorphous 
SiNPs at 1.96 10
12
 NPs mL
-1
 caused a significant attenuation in dilation as compared to PSS 
alone (Fig. 2). Incubation in CeSiNPs (50±4 nm) at 1.96 10
12
 NPs mL
-1
 led to a significant 
improvement in dilator responses (Fig.2). TEM transverse sections demonstrated uptake of 
both SiNPs and CeSiNPs into the cytoplasm of ECs (Fig.3) 
     
4. DISCUSSION 
 
In the present study, we demonstrate that while SiNPs significantly attenuated 
endothelial-dependent vasodilation, their surface modification with ceria lead to a significant 
improvement in dilator responses. Both SiNPs and CeSiNPs were rapidly internalised by 
ECs. There was no evidence of translocation through the elastic lamina or SMC layer. Jin et 
al. (2007) were also able to demonstrate that the majority of NPs that rapidly entered cells 
 6 
took place within the first 5 min and reached maximum uptake after a 30 min incubation 
period.
13
  
The attenuated dilation due to SiNP uptake, observed in the present study, may be 
related to the NP’s generation and stimulation of intracellular ROS. These can act as 
scavengers of nitric oxide, the major vasodilator in aortic vessels. SiNPs have a high 
concentration of surface OH
-
 groups on their surface and this may play an important role in 
ROS generation. ROS generation by SiNPs has previously been demonstrated in a number of 
cell types in vitro, including HUVECs,
7
 lung submucosal cells 
14
 and human keratoinocyte 
cells 
15
. The resultant oxidative stress has been shown to be a major cause of nanotoxicity, 
leading to endothelial dysfunction, DNA damage and apoptosis.
15,16
 For example, Duan et al 
(2013),
7
 were able to demonstrate that SiNP incubation with HUVECs led to a dose and time 
dependent cytotoxic influence on these cells (both necrosis and apoptosis) through DNA 
damage and cycle arrest, as well as inhibition of SOD and glutathione peroxidase enzymes.  
We demonstrate the rapid uptake of SiNPs and CeSiNPs in live viable aortic vessels, 
ex vivo. We show that while SiNPs of ~50 nm attenuate endothelial-dependent relaxation, 
ceria coating of these SiNPs leads to significant improvement in dilator responses. This study 
will inform the future fabrication of biocompatible SiNPs for use in imaging diagnostics. 
Furthermore, CeSiNPs may represent novel therapeutic tools for the protection and treatment 
of conditions where reduced dilator responses are observed. 
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FIGURE LEGENDS 
Figure 1:  TEM image of A) SiNPs (47±8 nm), B) ceria coated SiNPs (50±4 nm ) , C) 
enlarged image of ceria coated SiNP;  EDS analysis for D) SiNPs  and E) ceria coated SiNPs. 
 
Figure 2: The influence of amorphous silica nanoparticles (SiNP) and ceria coated silica 
nanoparticles (CeSiNPs) on endothelium-dependent vasodilator responses. The control is 
incubation in PSS alone.  ‘n’ is number of vessels. *=p<0.05, **=p<0.01 and ***=p<0.001, 
error bars=SEM.  
 
Figure 3: Representative TEM images showing uptake of A) CeSiNPs (9300mag) and B) 
CeSiNPs (30000mag), by endothelial cells lining aortic vessels.  
  
 10 
Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 11 
Figure 2 
 
 
 
 
 
 
 
 
  
 12 
 
Figure 3 
 
 
 
 
 
 
